Page last updated: 2024-09-03

sc 51089 and cicaprost

sc 51089 has been researched along with cicaprost in 1 studies

Compound Research Comparison

Studies (sc 51089)	Trials (sc 51089)	Recent Studies (post-2010) (sc 51089)	Studies (cicaprost)	Trials (cicaprost)	Recent Studies (post-2010) (cicaprost)
41	1	19	172	5	14

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baloch, M; Clapp, LH; Hall, S; Turcato, S	1

Other Studies

1 other study(ies) available for sc 51089 and cicaprost

Article	Year
Evidence that Ca2+-activated K+ channels play a major role in mediating the vascular effects of iloprost and cicaprost. European journal of pharmacology, 1998, Sep-04, Volume: 356, Issue:2-3 Topics: Animals; Antineoplastic Agents; Calcium; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Guinea Pigs; Hydrazines; Iloprost; Isoproterenol; Male; Muscle, Smooth, Vascular; Oxazepines; Phenylephrine; Potassium Channel Blockers; Potassium Channels; Prostaglandin Antagonists; Tetraethylammonium; Vasodilation; Vasodilator Agents	1998

Article

Year

Evidence that Ca2+-activated K+ channels play a major role in mediating the vascular effects of iloprost and cicaprost.

European journal of pharmacology, 1998, Sep-04, Volume: 356, Issue:2-3

Topics: Animals; Antineoplastic Agents; Calcium; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Guinea Pigs; Hydrazines; Iloprost; Isoproterenol; Male; Muscle, Smooth, Vascular; Oxazepines; Phenylephrine; Potassium Channel Blockers; Potassium Channels; Prostaglandin Antagonists; Tetraethylammonium; Vasodilation; Vasodilator Agents

1998